Mentalization-based treatment in groups for adolescents with Borderline Personality Disorder: 3- and 12-month follow-up of a randomized controlled trial.


Journal

European child & adolescent psychiatry
ISSN: 1435-165X
Titre abrégé: Eur Child Adolesc Psychiatry
Pays: Germany
ID NLM: 9212296

Informations de publication

Date de publication:
May 2021
Historique:
received: 06 11 2019
accepted: 28 04 2020
pubmed: 11 5 2020
medline: 11 5 2021
entrez: 11 5 2020
Statut: ppublish

Résumé

Mentalization-based treatment in groups (MBT-G) has never been tested in adolescents with Borderline Personality Disorder (BPD) in a randomized controlled trial. The current study aimed to test the long-term effectiveness of MBT-G in an adolescent sample with BPD or BPD features (≥ 4 DSM-5 BPD criteria). Hundred and eleven patients with BPD (n = 106) or BPD features (n = 5) were randomized to either (1) a 1-year modified MBT-G program comprising three MBT introductory sessions, five individual case formulation sessions, 37 weekly MBT group sessions, and six MBT-Parent sessions, or (2) treatment as usual (TAU), defined as at least 12 individual monthly treatment sessions with follow-up assessments at 3 and 12 months post treatment. The primary outcome was the score on the Borderline Personality Features Scale for Children (BPFS-C), and secondary outcomes included clinician-rated BPD symptoms and global level of functioning as well as self-reported self-harm, depression, externalizing and internalizing symptoms, and caregiver reports. There were no statistically significant differences between MBT-G and TAU on the primary outcome measure or any of the secondary outcomes. Both groups showed improvement on the majority of clinical and social outcomes at both follow-up points, although remission rates were modest with just 35% in MBT-G and 39% in TAU 2 years after inclusion into the study. MBT-G was not superior to TAU in improving borderline features in adolescents. Although improvement was observed equally in both interventions over time, the patients continued to exhibit prominent BPD features, general psychopathology and decreased functioning in the follow-up period, which points to a need for more research and better understanding of effective components in early intervention programs. The ClinicalTrials.gov identifier is NCT02068326.

Identifiants

pubmed: 32388627
doi: 10.1007/s00787-020-01551-2
pii: 10.1007/s00787-020-01551-2
doi:

Banques de données

ClinicalTrials.gov
['NCT02068326']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

699-710

Subventions

Organisme : Trygfonden
ID : 115638

Références

Achenbach TM (1991) Manual for the youth self-report and 1991 profile. University of Vermont Department of Psychiatry, Burlington
Achenbach TM (1991) Manual for the child behavior checklist 4-18 and 1991 profile. University of Vermont Department of Psychiatry, Burlington
Baldwin SA, Bauer DJ, Stice E, Rohde P (2011) Evaluating models for partially clustered designs. Psychol Methods 16(2):149–165
pubmed: 21517179 pmcid: 3987820
Bales DL, Verheul R, Hutsebaut J (2017) Barriers and facilitators to the implementation of mentalization-based treatment (MBT) for borderline personality disorder. Personal Ment Health 11(2):118–131
pubmed: 28488379
Bateman A, Fonagy P (1999) Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry 156:1563–1569
pubmed: 10518167
Bateman A, Fonagy P (2001) Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up. Am J Psychiatry 158:36–42
pubmed: 11136631
Bateman A, Fonagy P (2004) Mentalization-based treatment of BPD. J Personal Disord 18(1):36–51
Bateman A, Fonagy P (2008) 8-year follow-up of patients treated for borderline personality disorder: mentalization-based treatment versus treatment as usual. Am J Psychiatry 165:631–638
pubmed: 18347003
Bateman A, Fonagy P (2009) Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. Am J Psychiatry 166:1355–1364
pubmed: 19833787
Bateman A, Fonagy P (2016) Mentalization-based treatment for personality disorders – a practical guide. Oxford University Press, Oxford
Beck JS, Beck AT, Jolly JB, Steer RA (2012) Beck youth inventories of emotional & social impairment, 2nd edn. Dansk Psykologisk Forlag, Copenhagen
Beck E, Bo S, Gondan M, Poulsen S, Pedersen L, Pedersen J, Simonsen E (2016) Mentalization-based treatment in groups for adolescents with borderline personality disorder (BPD) or subthreshold BPD versus treatment as usual (M-GAB): study protocol for a randomized controlled trial. Trials 17(1):1–13
Beck E, Bo S, Jørgensen MS, Gondan M, Poulsen S, Storebø OJ, Andersen CF, Folmo E, Sharp C, Pedersen J, Simonsen E (2020) Mentalization-based treatment in groups for adolescents with borderline personality disorder: a randomized controlled trial. J Child Psychol Psychiatry 61(5):594–604
pubmed: 31702058
Becker DF, Grilo CM, Edell WS, Mcglashan TH (2002) Diagnostic efficiency of borderline personality disorder criteria in hospitalized adolescents: comparison with hospitalized adults. Am J Psychiatry 159(12):2042–2047
pubmed: 12450954
Chanen AM, Jackson HJ, Mcgorry PD, Allot KA, Clarkson V, Yuen HP (2004) Two-year stability of personality disorder in older adolescent outpatients. J Personal Disord 18(6):526–541
Chanen AM, Jackson HJ, McCutcheon LK, Jovev M, Dudgeon P, Yuen HP, McGorry PD (2008) Early intervention for adolescents with borderline personality disorder using cognitive analytic therapy: randomised controlled trial. Br J Psychiatry 193(6):477–484
pubmed: 19043151
Chanen AM, McCutcheon LK (2013) Prevention and early intervention for borderline personality disorder: current status and recent evidence. Br J Psychiatry 202:24–29
Chanen AM (2015) Borderline personality disorder in young people: are we there yet? J Clin Psychol 71(8):778–791
pubmed: 26192914
Chanen AM, Berk M, Thompson K (2016) Integrating early intervention for borderline and mood disorders. Harv Rev Psychiatry 24(5):330–341
pubmed: 27144298
Chanen AM, Sharp C, Hoffman P (2017) The global alliance for prevention and early intervention for borderline personality disorder. Prevention and early intervention for borderline personality disorder: a novel public health priority. World Psychiatry 16:215–216
pubmed: 28498598 pmcid: 5428197
Committee for Medicinal Products for Human Use (CMPH) (2015) Guideline on adjustment for baseline covariates in clinical trials. European Medicines Agency, London
Crick NR, Close DM, Woods K (2005) Borderline personality features in childhood: a short-term longitudinal study. Dev Psychopathol 17:1051–1070
pubmed: 16613430
Flight L, Allison A, Dimairo M, Lee E, Mandefield L, Walters SJ (2016) Recommendations for the analysis of individually randomised controlled trials with clustering in one arm–a case of continuous outcomes. BMC Med Res Methodol 16:1–13
Folmo EJ, Karterud SW, Bremer K, Walther KL, Kvarstein EH, Pedersen GAF (2017) The design of the MBT-G adherence and quality scale. Scand J Psychol 58:341–349
pubmed: 28718968
Gunderson J et al (2011) Ten-year course of borderline personality disorder: psychopathology and function from the collaborative longitudinal personality disorders study. Arch Gen Psychiatry 68(8):827–837
pubmed: 21464343 pmcid: 3158489
Ha C, Balderas JC, Zanarini MC, Oldham J, Sharp C (2014) Psychiatric comorbidity in hospitalized adolescents with borderline personality disorder. J Clin Psychiatry 75(5):e457–e464
pubmed: 24922498
Hayes AF (2009) Beyond Baron and Kenny: statistical mediation analysis in the new millennium. Commun Monogr 76(4):408–420
Hutsebaut J, Videler AC, Verheul R, Van Alphen SPJ (2019) Managing borderline personality disorder from a life course perspective: clinical staging and health management. Personal Disord Theory Res Treat 19(4):309–316
Jørgensen CR, Freund C, Boye R, Jordet H, Andersen D, Kjølbye M (2013) Outcome of mentalization-based and supportive psychotherapy in patients with borderline personality disorder: a randomized trial. Acta Psychiatr Scand 127:305–317
pubmed: 22897123
Jørgensen CR, Bøye R, Andersen D, Døssing Blaabjerg AH, Freund C, Jordet H, Kjølbye M (2014) Eighteen months post-treatment naturalistic follow-up study of mentalization-based therapy and supportive group treatment of borderline personality disorder: clinical outcomes and functioning. Nord Psychol 66(4):254–273
Karterud SW, Bateman AW (2011) Manual for mentaliseringsbasert psykoedukativ gruppeterapi (MBT-I). Gyldendal akademisk, Oslo
Karterud SW (2012) Manual for mentaliseringsbasert gruppeterapi (MBT-G). Gyldendal akademisk, Oslo
Karterud SW (2013) Personlighedsforstyrrelser i DSM-IV og ICD-10. In: Karterud SW, Wilberg T, Urnes O (eds) Personlighedspsykiatri, 1st edn. Akademisk Forlag, København, pp 209–281
Kvarstein EH, Pedersen G, Folmo E, Urnes Ø, Johansen MS, Hummelen B, Karterud S (2019) Mentalization-based treatment or psychodynamic treatment programmes for patients with borderline personality disorder–the impact of clinical severity. Psychol Psychother Theory Res Pract 92:91–111
Laurenssen E, Luyten P, Kikkert MJ, Westra D, Peen J, Soons MBJ et al (2018) Day hospital mentalization-based treatment v. specialist treatment as usual in patients with borderline personality disorder: randomized controlled trial. Psychol Med 48(15):2522–2529
pubmed: 29478425
Leichsenring F, Leibing E, Kruse J, New AS, Leweke F (2011) Borderline personality disorder. Lancet 377(9759):74–84
pubmed: 21195251
Linehan MM, Korslund KE, Harned MS et al (2015) Dialectical behavior therapy for high suicide risk in individuals with borderline personality disorder: a randomized clinical trial and component analysis. JAMA Psychiatry 72(5):475–482
pubmed: 25806661
McCauley E, Berk MS, Asarnow JR, Adrian M, Cohen J, Korslund K (2018) Efficacy of dialectical behavior therapy for adolescents at high risk for suicide a randomized clinical trial. JAMA Psychiatry 75(8):777–785
pubmed: 29926087 pmcid: 6584278
Mehlum L, Tormoen AJ, Ramberg M, Haga E, Diep LM, Laberg S, Groholt B (2014) Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior: a randomized trial. J Am Acad Child Adolesc Psychiatry 53(10):1082–1091
pubmed: 25245352
Mehlum L, Ramberg M, Tormoen AJ, Haga E, Diep LM, Stanley BH, Groholt B (2016) Dialectical behavior therapy compared with enhanced usual care for adolescents with repeated suicidal and self-harming behavior: outcomes over a one-year follow-up. J Am Acad Child Adolesc Psychiatry 55(4):295–300
pubmed: 27015720
Mehlum L, Ramleth R, Tørmoen AJ, Haga E, Diep LM, Stanley BH, Grøholt B (2019) Long term effectiveness of dialectical behavior therapy versus enhanced usual care for adolescents with self-harming and suicidal behavior. J Child Psychol Psychiatry 60(10):1112–1122
pubmed: 31127612
Newton-Howes G, Clark LA, Chanen A (2015) Personality disorder across the life course. Lancet 385(9969):727–734
pubmed: 25706218
Robinson P, Hellier J, Barett B, Barzdaitiene D, Bateman A, Bogaardt A et al (2016) The NOURISHED randomised controlled trial comparing mentalisation-based treatment for eating disorders (MBT-ED) with specialist supportive clinical management (SSCM-ED) for patients with eating disorders and symptoms of borderline personality disorder. Trials 17:549
pubmed: 27855714 pmcid: 5114835
Rossouw TI, Fonagy P (2012) Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry 51:1304–1313
pubmed: 23200287
Rubin DB (1987) Multiple imputation for non-response in surveys. John Wiley & Sons, New York
Santisteban DA, Mena MP, Muir J, McCabe BE, Abalo C, Cummings AM (2015) The efficacy of two adolescent substance abuse treatments and the impact of comorbid depression: results of a small randomized controlled trial. Psychiatr Rehabil J 38(1):55–64
pubmed: 25799306 pmcid: 5021542
Schuppert HM, Timmerman ME, Bloo J, van Gemert TG, Wiersema HM, Minderaa RB, Nauta MH (2012) Emotion regulation training for adolescents with borderline personality disorder traits: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry 51(12):1314–1323.e2
pubmed: 23200288
Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H et al (1983) A children’s global assessment scale. Arch Gen Psychiatry 40(11):1228–1231
Sharp C, Mosko O, Chang B, Ha C (2011) The cross-informant concordance and concurrent validity of the borderline personality features scale for children in a community sample of boys. Clin Child Psychol Psychiatry 16(3):335–349
pubmed: 20921039
Sharp C, Green KL, Yaroslavsky I, Venta A, Zanarini MC, Pettit J (2012) The incremental validity of borderline personality disorder relative to major depressive disorder for suicidal ideation and deliberate self-harm in adolescents. J Personal Disord 26(6):927–938
Stepp SD, Pilkonis PA, Hipwell AE, Loeber R, Stouthamer-Loeber M (2010) Stability of borderline personality disorder features in girls. J Pers Disord 24(4):460–472
pubmed: 20695806 pmcid: 2920503
Thastum M, Ravn K, Sommer S, Trillingsgaard A (2009) Reliability, validity and normative data for the Danish beck youth inventories: development and aging. Scand J Psychol 50:47–54
pubmed: 18980602
Thompson KN, Jackson H, Cavelti M, Betts J, Mccutcheon L, Jovev M, Chanen AM (2019) The clinical significance of subthreshold borderline personality disorder features in outpatient youth. J Personal Disord 33(1):71–81
Vrouva I, Fonagy P, Fearon PRM, Rossouw TI (2010) The risk-taking and self-harm inventory for adolescents: development and psychometric evaluation. Psychol Assess 22:852–865
pubmed: 20919771
Winograd G, Cohen P, Chen H (2008) Adolescent borderline symptoms in the community: prognosis for functioning over 20 years. J Child Psychol Psychiatry 49:933–941
pubmed: 18665882
Zanarini MC, Frankenburg FR (2001) Zanarini rating scale for borderline personality disorder (ZAN-BPD). Harvard Medical School, Belmont
Zanarini MC, Vujanovic AA, Parachini EA, Boulanger JL, Frankenburg FR, Hennen J (2003) Zanarini rating scale for borderline personality disorder (Zan-BPD): a continuous measure of DSM-IV borderline psychopathology. J Personal Disord 17(3):233–242
Zanarini MC et al (2005) The McLean study of adult development (MSAD): overview and implications of the first six years of prospective follow-up. J Personal Disord 19(5):505–523
Zanarini MC, Frankenburg FR, Reich DB, Silk KR, Hudson JI, McSweeney LB (2007) The subsyndromal phenomenology of borderline personality disorder: a 10-year follow-up study. Am J Psychiatry 164(6):929–935
pubmed: 17541053
Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G (2012) Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and axis ii comparison subjects: a 16-year prospective follow-up study. Am J Psychiatry 169(5):476–483
pubmed: 22737693 pmcid: 3509999

Auteurs

Mie Sedoc Jørgensen (MS)

Psychiatric Research Unit, Region Zealand, Fælledvej 6, 4200, Slagelse, Denmark. mipjo@regionsjaelland.dk.
Child and Adolescent Psychiatric Department, Region Zealand, Smedegade 16, 4000, Roskilde, Denmark. mipjo@regionsjaelland.dk.
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. mipjo@regionsjaelland.dk.

Ole Jakob Storebø (OJ)

Psychiatric Research Unit, Region Zealand, Fælledvej 6, 4200, Slagelse, Denmark.
Child and Adolescent Psychiatric Department, Region Zealand, Smedegade 16, 4000, Roskilde, Denmark.
Department of Psychology, University of Southern Denmark, Odense, Denmark.

Sune Bo (S)

Psychiatric Research Unit, Region Zealand, Fælledvej 6, 4200, Slagelse, Denmark.
Child and Adolescent Psychiatric Department, Region Zealand, Smedegade 16, 4000, Roskilde, Denmark.

Stig Poulsen (S)

Department of Psychology, University of Copenhagen, 2A Øster Farimagsgade, 1353, Copenhagen, Denmark.

Matthias Gondan (M)

Department of Psychology, University of Copenhagen, 2A Øster Farimagsgade, 1353, Copenhagen, Denmark.

Emma Beck (E)

Psychiatric Research Unit, Region Zealand, Fælledvej 6, 4200, Slagelse, Denmark.
Child and Adolescent Psychiatric Department, Region Zealand, Smedegade 16, 4000, Roskilde, Denmark.
Department of Psychology, University of Copenhagen, 2A Øster Farimagsgade, 1353, Copenhagen, Denmark.

Andrew M Chanen (AM)

Orygen, Melbourne, Australia, and Centre for Youth Mental Health, University of Melbourne, Melbourne, Australia.

Anthony Bateman (A)

Research Department of Clinical, Education and Health Psychology, University College London, London, UK.

Jesper Pedersen (J)

Child and Adolescent Psychiatric Department, Region Zealand, Smedegade 16, 4000, Roskilde, Denmark.

Erik Simonsen (E)

Psychiatric Research Unit, Region Zealand, Fælledvej 6, 4200, Slagelse, Denmark.
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH